Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

18300results about "Genetic engineering" patented technology

Anti-human serum albumin nano antibody and application thereof

The invention provides an anti-human serum albumin nano antibody and application thereof, and belongs to the technical field of antibodies. The invention provides an anti-human serum albumin nano antibody HSA-32 with relatively high affinity, and the anti-human serum albumin nano antibody HSA-32 is subjected to humanized transformation, so that three obtained humanized anti-human serum albumin nano antibodies can be used for reducing the immunogenicity of the HSA-32 and improving the immunogenicity of the HSA-32; and high specificity and high affinity of combination with the human serum albumin and stability and solubility of the antibody are maintained. The anti-human serum albumin nano antibody can be used for separation, purification and detection of human serum albumin and separation and purification of polypeptide, protein or antibody drugs fused with the anti-human serum albumin nano antibody. Meanwhile, the anti-human serum albumin nano-antibody can effectively prolong the half-life period of polypeptide, protein and antibody drugs fused with the anti-human serum albumin nano-antibody, and can be used for developing long-acting polypeptide, protein or antibody drugs.
Owner:INST OF ZOOLOGY CHINESE ACAD OF SCI

Engineering bacterium for co-expressing D-mannitol dehydrogenase and D-glucose dehydrogenase and application

The invention discloses construction and application of an engineering bacterium for co-expressing D-mannitol dehydrogenase and D-glucose dehydrogenase, and belongs to the technical field of genetic engineering. The technical problem to be solved by the invention is how to co-express D-mannitol dehydrogenase and D-glucose dehydrogenase through a biosynthetic pathway. In order to solve the technical problem, the invention provides recombinant escherichia coli. The recombinant escherichia coli is characterized by containing a D-mannitol dehydrogenase gene, a D-glucose dehydrogenase gene, a glucokinase gene, an acetyl coenzyme A synthetase gene, a D-lactose transporter gene, a D-glucose PTS permease-free gene and a pyruvate oxidase-free gene. And no regulator gene of galactose operon is contained. The invention establishes a preparation method for co-producing D-mannitol and sodium gluconate, which has guiding significance for the production of D-mannitol and sodium gluconate.
Owner:MICROCYTO BIOTECHNOLOGY (BEIJING) CO LTD

CYP450 zymoprotein capable of catalyzing formation of neoandrographolide aglycone, coding gene and application

The invention provides a CYP450 zymoprotein capable of catalyzing formation of neoandrographolide aglycone, a coding gene and application, and belongs to the field of biology. According to the present invention, bioinformatics analysis and differential expression analysis are performed on transcriptome data of different tissue parts, the gene ApCYP71BE50 capable of catalyzing (4R, 5S, 9R, 10S)-labda-8 (17), 13-dien-15, 19-diol to form the neoandrographolide aglycone is excavated, and it is verified that the CYP450 enzyme protein encoded by the gene ApCYP71BE50 can perform continuous oxidation on the C16 site of (4R, 5S, 9R, 10S)-labda-8 (17), 13-dien-15, 19-diol to form the neoandrographolide aglycone. The invention provides an important gene element for biosynthesis of andrographolide, and also provides a key gene locus for molecular design breeding of andrographis paniculata.
Owner:INSTITUTE OF CHINESE MATERIA MEDICA CHINA ACADEMY OF CHINESE MEDICAL SCIENCES

Method for producing human milk oligosaccharide

The invention belongs to the technical field of gene engineering, and particularly relates to mutants of murA and ygeA genes and application of the mutants in production of human milk oligosaccharides. According to the invention, murA and ygeA genes of escherichia coli are edited by using a gene editing technology, so that a genetic engineering chassis strain carrying murA and ygeA mutants is obtained. Further, the chassis strain is applied to the construction process of production strains of LNT II, LNnT, LNT, 3 '-SL and 6'-SL, and the yield of the LNT II, the LNnT, the LNT, the 3 '-SL and the 6'-SL is further increased.
Owner:TIANJIN UNIV OF SCI & TECH

Monoclonal antibody or antigen binding fragment thereof for detecting folic acid and binding protein complex thereof, preparation method and application thereof

The invention relates to a monoclonal antibody for detecting folic acid and a binding protein complex thereof or an antigen binding fragment thereof, and a preparation method and application thereof, the monoclonal antibody or the antigen binding fragment thereof comprises: (1) a heavy chain variable region having an amino acid sequence as shown in SEQ ID NO.1, SEQ ID NO.2 and SEQ ID NO.3, HCDR1, HCDR2 and HCDR3, and (2) a heavy chain variable region having an amino acid sequence as shown in SEQ ID NO.3; the light chain variable region is provided with an LCDR1, an LCDR2 and an LCDR3, and the amino acid sequences of the LCDR1, the LCDR2 and the LCDR3 are respectively shown as SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO.6. The monoclonal antibody or the antigen binding fragment thereof can bind folic acid and a protein compound thereof with high specificity and high affinity, so that the detection accuracy and sensitivity of folic acid are improved, the limitation that a traditional competition method detection reagent is low in sensitivity and poor in clinical correlation is broken through, and sandwich method immunodetection of folic acid is realized.
Owner:NANJING OKAY BIOTECHNOLOGY CO LTD +1

Carbonyl reductase mutant and method for catalytically synthesizing high-concentration bose by using carbonyl reductase mutant

The invention discloses a carbonyl reductase mutant and a method for catalytically synthesizing high-concentration glassine by using the carbonyl reductase mutant, and belongs to the field of biological catalysis. According to the invention, a one-pot method is adopted to catalyze beta-acetone xyloside to synthesize high-concentration boine, carbonyl reductase CnMDR coded enzyme and rational design of a substrate pocket key are combined with multiple sites, beneficial mutations are combined, dominant mutant enzyme recombinant bacteria are used as a catalyst, beta-acetone xyloside is used as a substrate, and formate dehydrogenase variants and NAD + kinase are introduced at the same time, so that the high-concentration boine is synthesized. The NADP < + >-NADPH coenzyme is driven to circulate, the yield of the synthesized boine is 200g / L, and the conversion rate is gt; the ee value of the product is gt; the invention provides a one-pot efficient low-cost method for synthesizing the boine, only a trace amount (0.3 mM) of coenzyme needs to be added, byproducts in a reaction system are easy to separate, and great convenience is provided for industrial large-scale production.
Owner:JIANGNAN UNIV

Improved engineering strain for producing L-isoleucine through methyl malic acid way as well as construction method and application of improved engineering strain

The invention belongs to the technical field of biology, and relates to an escherichia coli engineering strain for producing L-isoleucine through a methyl malic acid way as well as a construction method and application of the escherichia coli engineering strain. According to the invention, Escherichia coli BW25113 is used as a chassis strain, and a methyl malic acid synthase high-activity mutant gene cimA3.7, an isopropyl malic acid isomerase gene GsleuCD, a 3-isopropyl malic acid dehydrogenase gene AfleuB and a leucine dehydrogenase gene Lsleudh are over-expressed; a methyl malic acid absorption protein gene is over-expressed, and a branched chain amino acid transport system is modified to improve the exosome of the L-isoleucine; all methyl malic acid pathway related genes are integrated to a genome of a chassis strain, and a plasmid-free L-isoleucine production strain is constructed; the copy number of a key gene on a genome is optimized, and the yield of the engineering strain L-isoleucine is increased by introducing a non-oxidative glycolysis approach. The yield of the L-isoleucine after the engineering strain is fermented for 34 hours in a fermentation tank is 56.6 g / L.
Owner:INSTITUTE OF ANIMAL SCIENCES OF CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Anti-IL-6 nano antibody, recombinant nano antibody, recombinant vector and application

The invention belongs to the technical field of immunology, and particularly relates to an anti-IL-6 nano antibody, a recombinant nano antibody, a recombinant vector and application. The anti-IL-6 nano antibody disclosed by the invention comprises a heavy chain variable region containing CDR1, CDR2 and CDR3, and has the functions of identifying and combining IL-6. The invention also discloses a recombinant nano antibody containing the nano antibody, a recombinant vector and a detection agent, and applications of the nano antibody, the recombinant nano antibody, the recombinant vector and the detection agent in preparation of drugs for treating IL-6 related diseases. The nano antibody, the recombinant nano antibody and the recombinant vector provided by the invention can recognize and combine IL-6, and have a potential effect of treating IL-6-related diseases.
Owner:DONGGUAN SOUTHEAST CENTRAL HOSPITAL (DONGGUAN SOUTHEAST TRADITIONAL CHINESE MEDICINE MEDICAL SERVICE CENTER DONGGUAN FIRST HOSPITAL AFFILIATED TO GUANGDONG MEDICAL UNIVERSITY)

Targeting IL-6 nano antibody and application thereof

The invention belongs to the technical field of immunology, and particularly relates to a targeted IL-6 biological nano antibody and application thereof. The invention discloses a nano antibody for targeting IL-6, which comprises a heavy chain variable region containing CDR1, CDR2 and CDR3, and has the functions of identifying and combining IL-6. The invention also discloses a composition containing the nano antibody or the IL-6 binding molecule, and an application of the composition containing the nano antibody and the IL-6 binding molecule in preparation of drugs for treating IL-6 related diseases. The nano antibody, the BCMA binding molecule and the composition can recognize and bind IL-6, and have a potential effect of treating IL-6 related diseases.
Owner:DONGGUAN SOUTHEAST CENTRAL HOSPITAL (DONGGUAN SOUTHEAST TRADITIONAL CHINESE MEDICINE MEDICAL SERVICE CENTER DONGGUAN FIRST HOSPITAL AFFILIATED TO GUANGDONG MEDICAL UNIVERSITY)

Monoclonal antibody for distinguishing hog cholera lapinized virus vaccine strain and epidemic strain and application thereof

The invention discloses a monoclonal antibody for distinguishing a hog cholera lapinized virus vaccine strain and a hog cholera lapinized virus epidemic strain and application of the monoclonal antibody, and belongs to the field of immune globulin. The E2 protein monoclonal antibody or the antigen binding fragment thereof comprises a heavy chain variable region (SEQ ID No.1) and a light chain variable region (SEQ ID No.3). The invention also discloses an ELISA method for identifying and distinguishing hog cholera lapinized virus vaccine strains and epidemic strains by using the E2 protein monoclonal antibody. The monoclonal antibody disclosed by the invention has a specific reaction with the swine fever virus epidemic strain and does not react with the swine fever lapinized virus vaccine strain, and the swine fever lapinized virus vaccine strain and the epidemic strain can be accurately identified and distinguished by utilizing an ELISA competition method established by the monoclonal antibody. The monoclonal antibody provided by the invention can be used in the fields of CSFV immunization, serological diagnosis of wild viruses, immune effect evaluation, related experiments and the like, and provides antibody resources for effective detection and purification of CSFV.
Owner:JILIN UNIVERSITY +1

BaEV retrovirus vector packaging cell strain as well as preparation method and application thereof

The invention provides a BaEV retrovirus vector packaging cell strain and a preparation method and application thereof, the BaEV retrovirus vector packaging cell strain is preserved in Guangdong Microbial Culture Collection Center on July 17, 2024, and the preservation number is GDMCC No: 64874. The invention discloses a BaEV retrovirus stable packaging cell strain which is used for low-cost, high-quality and high-efficiency large-scale industrial preparation of pseudoviruses and application of the pseudoviruses in efficient transduction of cell therapy products.
Owner:SHENZHEN CELL VALLEY BIOMEDICAL CO LTD +1

Murine anti-PBP2a hybridoma cell strain, monoclonal antibody and application

The invention relates to a mouse anti-PBP2a hybridoma cell strain, a monoclonal antibody and application of the mouse anti-PBP2a hybridoma cell strain, staphylococcus aureus PBP2a protein is extracted as an antigen, after the high-purity antigen is obtained, a good immunoreaction is aroused in a mouse body, then a hybridoma technology is adopted, two cell strains with high affinity and specificity are screened, and the corresponding antibody is prepared; the two antibodies are used as a gold-labeled antibody and a coating antibody in a colloidal gold immunoassay kit, and the kit can be used for detecting PBP2a protein in methicillin-resistant staphylococcus aureus and can be used for developing related in-vitro diagnostic reagents.
Owner:TIANJIN ERA BIOLOGY TECH CO LTD +1

Monoclonal antibody for identifying canine distemper virus H protein, detection test strip and application

The invention discloses a monoclonal antibody for identifying canine distemper virus H protein, a detection test strip and application. The monoclonal antibody comprises a monoclonal antibody 5-8H or a monoclonal antibody 9-7B and has high specificity and sensitivity, the two antibodies can recognize different epitopes, and a detection test strip can be prepared through a double-antibody sandwich method. Tests prove that the monoclonal antibody provided by the invention has no obvious cross reaction on canine parvovirus, canine adenovirus, canine coronavirus and canine parainfluenza virus in preparation of a colloidal gold test strip for detecting the canine distemper virus, and has good specificity and higher sensitivity.
Owner:HUAZHONG AGRI UNIV

Monoclonal antibody 4F6 for HPV16 type E7 protein detection and application

The invention belongs to the technical field of biological detection, and particularly relates to a monoclonal antibody 4F6 for HPV16 type E7 protein detection and application. The heavy chain variable region CDR sequences and the light chain variable region CDR sequences of the antibody are SEQ ID NO.1-3 and SEQ ID NO.4-6 respectively, and the antibody can be specifically combined with HPV16 type E7 protein without cross reaction. A double-antibody sandwich ELISA detection system constructed based on the antibody is combined with a biotin-avidin amplification technology, the sensitivity reaches 100 pg / mL, and the antibody is suitable for rapid detection of the HPV16 type E7 protein in a cervical exfoliated cell sample. The invention further provides the HPV16 type E7 recombinant protein which is obtained through prokaryotic expression and has immunocompetence, and the HPV16 type E7 recombinant protein is applied to antibody screening and detection. Compared with nucleic acid detection, the method has a lower false positive rate, can be used for early screening of cervical cancer and precancerous lesions, and has a good application prospect.
Owner:BEIJING SUBENYUANHE BIOTECHNOLOGY CO LTD

D-psicose 3-epimerase mutant and application thereof

According to the D-psicose 3-epimerase mutant and the application thereof, the D-psicose 3-epimerase mutant is obtained through protein C-terminal sequence modification, software analysis and sequence alignment of different sources of D-psicose 3-epimerase, the half-life period of the mutant enzyme at 60 DEG C, 70 DEG C and 80 DEG C is prolonged, and the activity of the mutant enzyme is improved. The substrate affinity and conversion efficiency of the enzyme to D-fructose as a substrate for synthesizing D-psicose are improved, and the Tm value of the mutant is 73.23 DEG C and is improved by 11.98 DEG C compared with that of a wild type; the half-life period at the temperature of 60 DEG C is 255.35 min and is 17.60 times that of a wild type, the problem that the half-life period of the wild type is too short at the high temperature is solved, the relative action time of the mutant enzyme is long, the yield of the product D-psicose is remarkably increased by applying the genetically engineered bacterium containing the modified enzyme for biotransformation, the product yield is increased by 4.3%, the equilibrium conversion rate reaches 33%, and the yield of the product is greatly increased. And a green, environment-friendly, sanitary and safe biological preparation method is provided for the preparation process of the D-psicose.
Owner:ZHEJIANG UNIV OF TECH +1

Biosynthesis system for high yield of 1, 6-hexamethylenediamine and application of biosynthesis system

The invention discloses a biosynthesis system for high-yield 1, 6-hexamethylenediamine and application of the biosynthesis system, and belongs to the technical field of biology. According to the method, key genes which are excavated and optimized in a 1, 6-hexamethylenediamine biosynthetic pathway are co-expressed in a single cell module or a multi-cell module, and different enzyme elements expressed by the cell module are subjected to enzyme cascade reaction, so that 1, 6-hexamethylenediamine can be efficiently synthesized by taking caprolactam or 6-aminocaproic acid as a substrate; furthermore, after the carboxylic acid reductase MaCAR is mutated, the catalytic activity of the carboxylic acid reductase MaCAR can be remarkably improved, and the yield of the 1, 6-hexamethylenediamine is further improved; in addition, the biosynthesis system disclosed by the invention directly takes the cell module as a whole-cell catalyst, and an enzyme purification step is avoided, so that the biosynthesis system has the advantage of low cost.
Owner:HUBEI UNIV

Application of TaNLP-3B gene and related biological materials thereof in regulating and controlling protein content of plant seeds

The invention discloses an application of a TaNLP-3B gene and a related biological material thereof in regulating and controlling the protein content of plant seeds. The gene TaNLP-3B is cloned from wheat, the gene TaNLP-3B is overexpressed in wheat Fielder to obtain a TaNLP-3B transgenic overexpressed plant, and a detection result shows that the protein content in wheat seeds can be remarkably increased by more than 40% through TaNLP-3B gene overexpression, so that the TaNLP-3B gene has an effect of regulating and controlling the protein content in the plant seeds, and the protein content in the wheat seeds can be increased by more than 40%. The method can be applied to plant breeding or quality improvement.
Owner:INST OF GENETICS & DEVELOPMENTAL BIOLOGY CHINESE ACAD OF SCI

Anti-human adenovirus antibody, and preparation method therefor and use thereof

An anti-human adenovirus (AdV) antibody, a preparation method, a kit comprising the antibody, and the related use thereof. The anti-human adenovirus antibody can specifically bind hexon proteins of various types of adenoviruses, shows high sensitivity and high specificity for adenoviruses, can be used for detecting various types of adenoviruses, greatly increases the detection rate of adenoviruses, reduces the detection cost, and provides a feasible scheme for rapid detection of adenoviruses in the respiratory tract and the digestive tract.
Owner:ZHUHAI HEAVYBIO CO LTD

Acyltransferase mutant and application thereof in synthesis of N-acetyl-trans-4-hydroxyproline

The invention discloses an acyltransferase mutant and application of the acyltransferase mutant in synthesis of N-acetyl-trans-4-hydroxyproline, and belongs to the technical field of enzyme engineering. The acyltransferase mutant provided by the invention contains 10th and 95th mutations on the basis of a corresponding amino acid sequence, such as a sequence as shown in SEQ ID NO.1, or contains 62nd or 64th mutations while containing the 10th and 95th mutations. Compared with an original enzyme before mutation, the acyltransferase mutant obtained by the invention has higher acyltransferase activity, and the conversion rate of trans-4-hydroxy-L-proline is greatly improved, so that the yield of N-acetyl-trans-4-hydroxy proline is further improved, and the yield of N-acetyl-trans-4-hydroxy proline is improved. After the surfactant and the metal ions are added, the yield of the N-acetyl-trans-4-hydroxyproline synthesized by the mutant D62K / D10V / D95I under the catalysis is up to 18.7 g / L.
Owner:KELAINI COSMETICS TECH CO LTD +1

Barley HvPHR1 gene and application of barley HvPHR1 gene in aspect of increasing phosphorus content of barley

According to the barley HvPHR1 gene and the application thereof in the aspect of increasing the phosphorus content of barley, rice PHR2 homologous protein serves as bait, homologous comparison means is utilized, it is found that two PHR proteins HvPHR1 and HvPHR2 exist in barley, and it is found that the content of inorganic phosphorus in barley leaves can be remarkably increased through overexpression of the HvPHR1 gene in an HvPHR1 overexpression strain with the normal phosphorus concentration being 200 micrometers NH4H2PO4 and an HvPHR1 overexpression strain with the low phosphorus concentration being 10 micrometers NH4H2PO4 hydroponic culture for three weeks and a wild type control (GP). In conclusion, the function of the HvPHR1 gene in barley low phosphorus stress is defined, and a theoretical basis is provided for cultivation of new phosphorus-efficient barley varieties.
Owner:ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES

Peroxidase AniUPO or mutant thereof, application of peroxidase AniUPO or mutant thereof in synthesis of alpha-hydroxyl beta-ketoester derivative and method for synthesizing alpha-hydroxyl beta-ketoester derivative

The invention relates to peroxidase AniUPO or a mutant of the peroxidase AniUPO, application of the peroxidase AniUPO in synthesis of alpha-hydroxyl beta-ketoester derivatives and a method for synthesizing the alpha-hydroxyl beta-ketoester derivatives, and belongs to the field of enzyme engineering. The invention provides a peroxidase AniUPO mutant, which is an amino acid sequence obtained by taking wild type peroxidase AniUPO with an amino acid sequence as shown in SEQ ID NO.1 as a parent and mutating the wild type peroxidase AniUPO with the amino acid sequence as shown in SEQ ID NO.1. The invention also provides a DNA (Deoxyribonucleic Acid) molecule for coding the peroxidase AniUPO mutant, an expression vector, a host cell and a method for synthesizing the chiral alpha-hydroxyl beta-ketone ester derivative. Compared with a wild type, the peroxidase mutant has the advantages of higher catalytic activity and better selectivity, applicable substrate types can be expanded to various cyclic and non-cyclic beta-ketone ester substrates, expensive catalysts and ligands are not needed, reaction conditions are mild, and potential industrial application prospects are achieved.
Owner:THE WEST CHINA SECOND UNIV HOSPITAL OF SICHUAN

Development, preparation and application of carbapenemase immunochromatography kit

The invention discloses development, preparation and application of a carbapenemase immunochromatography kit, and belongs to the technical field of biological medicines. According to comparison of amino acid sequences of five common carbapenemase variants of KPC, IMP, NDM, VIM and OXA48 types, the immunogen is prepared from conserved epitope sequences obtained respectively. A mouse is immunized, and a specific antibody pair which is strong in affinity and can be combined with multiple variants is obtained through multi-platform screening. On the basis, the carbapenemase quintuplet detection kit is developed by utilizing an immunochromatography method, has the advantages of high sensitivity, good specificity, capability of covering various drug-resistant variants, capability of detecting multiple targets at one time and rapidness and convenience in detection, and provides important help for clinical auxiliary diagnosis and medication guidance.
Owner:JIANGSU MEDOMICS MEDICAL TECHNOLOGY CO LTD

A recombinant yeast with high squalene production, and its construction method and use

PendingCN119752658AFungiMicroorganism based processesEnzyme GenePhosphotransferase Gene
The present invention relates to a recombinant yeast with high squalene production, a construction method and a use thereof, wherein the recombinant yeast is a saccharomyces cerevisiae that expresses or overexpresses HMGR gene, ADA gene, LEU2 gene, MVA pathway gene and squalene synthase gene ERG9. The present invention integrates acetaldehyde dehydrogenase gene ADA and HMG-CoA reductase gene tHMGR in multiple copies in saccharomyces cerevisiae, integrates the screened high-activity phosphoketolase gene PK and phosphotransacetylase gene PTA, weakens epoxysqualene synthesis, strengthens the mevalonate pathway, overexpresses yeast endogenous squalene synthase gene, etc. to obtain a recombinant yeast with high squalene production, so that the production in the shake flask stage of the production process exceeds 5g / L, and the production in the fed batch fermentation stage exceeds 50g / L, breaking through the current bottleneck of microbial synthesis of squalene production, and is suitable for practical promotion and application.
Owner:SHANGHAI RECOM BIOTECHNOLOGY CO LTD

Saccharomyces cerevisiae strain for efficiently synthesizing cordycepin as well as construction method and application thereof

The invention relates to a saccharomyces cerevisiae strain for efficiently synthesizing cordycepin as well as a construction method and application of the saccharomyces cerevisiae strain, and belongs to the technical field of microbial genetic engineering. The construction method provided by the invention comprises the following steps: carrying out multi-copy genome integrated expression on heterologous codon optimized 2 '-carbonyl-3'-deoxyadenosine reductase genes and 3 '-adenosine monophosphate phosphohydrolase genes, so as to increase the dosage of key enzymes; and supplementing the defective gene of the engineering strain to obtain the saccharomyces cerevisiae strain B5U3 with high yield of cordycepin. According to the obtained saccharomyces cerevisiae strain for efficiently synthesizing the cordycepin, the cordycepin yield reaches 2.92 g / L after shake flask fermentation, the cordycepin yield reaches 7.5 g / L after fermentation in a fermentation tank, and a foundation is laid for safer and more reliable industrial production of the cordycepin.
Owner:NANJING TECH UNIV

Preparation of targeting LYPD3 antibody and application of targeting LYPD3 antibody in tumor immunotherapy

The invention discloses preparation of a targeting LYPD3 antibody and application of the targeting LYPD3 antibody in tumor immunotherapy. The antibody or antigen binding fragment thereof comprises a heavy chain variable region having CDR-H1, CDR-H2 and CDR-H3 and a light chain variable region having CDR-L1, CDR-L2 and CDR-L3 wherein CDR-H1, CDR-H2 and CDR-H3 comprise the amino acid sequences of SEQ ID NO: 3, SEQ ID NO: 4 and SEQ ID NO: 5, respectively, and CDR-L1, CDR-L2 and CDR-L3 comprise the amino acid sequences of SEQ ID NO: 6, SEQ ID NO: 7 and SEQ ID NO: 8, respectively.
Owner:SUZHOU INST OF SYST MEDICINE

A monoclonal antibody combination for HPV18 type E7 protein detection and its application

The present invention belongs to the field of biological detection technology, specifically relating to a monoclonal antibody combination for detecting HPV18 E7 protein and its application. This combination consists of monoclonal antibodies 5F8 and 6G6, wherein the heavy and light chain variable regions of 5F8 and 6G6, respectively, contain specific complementarity-determining region sequences (as shown in SEQ ID NOs. 1 to 12), conferring high specificity for HPV18 E7 protein. Verification using a double-antibody sandwich ELISA and a biotin-avidin amplification system demonstrated that this antibody combination specifically recognizes HPV18 E7 protein, exhibits no cross-reactivity with other high-risk HPV oncoproteins, and exhibits a detection sensitivity of 1 ng / mL. This combination can be used to construct detection systems such as ELISA kits and immunochromatographic test strips, suitable for rapid screening of HPV18 E7 protein in cervical exfoliated cell samples.
Owner:BEIJING SUBENYUANHE BIOTECHNOLOGY CO LTD

Plants with increased herbicide tolerance and methods of production and use thereof

PCT designated stage expiredWO2025006490A2HydrolasesGenetic engineeringBiotechnologyPlant cell
Provided herein are newly identified genes encoding proteins involved in herbicide detoxification processes in plants. It is demonstrated that these genes and their encoded proteins are involved in herbicide detoxification processes in plants and increased expression of these genes can increase herbicide tolerance in plants. Accordingly, methods for generating a plant with increased herbicide tolerance is provided, including gene-editing and transformation methods that increase the level of the one or more herbicide detoxification genes or gene products in plants. Also provided are the plants, seeds, plant cells, or plant parts generated by or during these methods.
Owner:THE BOARD OF TRUSTEES OF THE UNIV OF ILLINOIS